Compare YDES & THFF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
| Metric | YDES | THFF |
|---|---|---|
| Founded | 2013 | 1984 |
| Country | Taiwan | United States |
| Employees | N/A | N/A |
| Industry | | Major Banks |
| Sector | | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 894.2M | 721.3M |
| IPO Year | N/A | N/A |
| Metric | YDES | THFF |
|---|---|---|
| Price | $10.37 | $66.25 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $60.00 |
| AVG Volume (30 Days) | 39.8K | ★ 82.0K |
| Earning Date | 03-30-2026 | 02-03-2026 |
| Dividend Yield | N/A | ★ 3.40% |
| EPS Growth | N/A | ★ 66.91 |
| EPS | N/A | ★ 6.68 |
| Revenue | $510,360.00 | ★ $253,640,000.00 |
| Revenue This Year | N/A | $14.53 |
| Revenue Next Year | N/A | $3.50 |
| P/E Ratio | ★ N/A | $9.87 |
| Revenue Growth | ★ 45.76 | 25.82 |
| 52 Week Low | $5.30 | $42.05 |
| 52 Week High | $31.00 | $69.21 |
| Indicator | YDES | THFF |
|---|---|---|
| Relative Strength Index (RSI) | 36.59 | 56.50 |
| Support Level | $10.81 | $65.53 |
| Resistance Level | $11.80 | $69.19 |
| Average True Range (ATR) | 0.76 | 1.53 |
| MACD | -0.10 | 0.01 |
| Stochastic Oscillator | 13.69 | 55.60 |
YD Bio Ltd is a biopharmaceutical company focusing on blood-based cancer detection, the development of stem cell- and exosome-based therapeutics with the potential to transform the treatment of a wide spectrum of diseases with high unmet medical need and serving as a trusted supplier of clinical testing drugs for pharmaceutical companies. Stem cell therapy uses versatile cells to repair or regenerate damaged tissues, offering innovative treatments for injuries, degenerative diseases, and immune disorders with potential for personalized medicine and tissue engineering.
First Financial Corp operates as a financial holding company, which is engaged in the provision of financial services in the United States. The company offers a wide variety of financial services including commercial, mortgage, and consumer lending, lease financing, trust account services, depositor services and insurance services, through its subsidiaries. Its primary source of revenue is derived from loans to customers and investment activities.